首页> 外文期刊>Vaccine >Direct effectiveness of pneumococcal polysaccharide vaccine against invasive pneumococcal disease and non-bacteremic pneumococcal pneumonia in elderly population in the era of pneumococcal conjugate vaccine: A case-control study
【24h】

Direct effectiveness of pneumococcal polysaccharide vaccine against invasive pneumococcal disease and non-bacteremic pneumococcal pneumonia in elderly population in the era of pneumococcal conjugate vaccine: A case-control study

机译:肺炎球菌疫苗疫苗对肺炎球菌共轭疫苗时代的老年人口侵袭性肺炎球菌疫苗和非杀菌性肺炎球菌肺炎的直接有效性:病例对照研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background: While herd effects and serotype replacement by childhood pneumococcal protein conjugated vaccines (PCVs) continues to accumulate worldwide, direct effectiveness of 23-valent pneumococcal polysaccharide vaccine (PPV23) against pneumococcal diseases in the elderly has been challenged. We estimated the direct effectiveness of PPV23 in the elderly population.
机译:背景:虽然儿童肺炎球菌蛋白共轭疫苗(PCVs)替代的畜群效果和血清型继续在全球范围内积累,但是23价肺炎球菌多糖疫苗(PPV23)对老年人肺炎球菌疾病的直接有效期受到挑战。 我们估计了PPV23在老年人口中的直接效益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号